Arch Venture Partners
SEC exempt reporting adviser (venture capital exemption).
- Website
- HTTP://ARCHVENTURE.COM
- HQ
- IL
Arch Venture Partners backs disruptive science companies, following the science to found companies based on revolutionary technologies. Its team includes co-founders Robert Nelsen and Keith Crandell, along with managing directors, partners, and venture partners. Portfolio companies include Agios Pharmaceuticals in gene-targeted cancer therapeutics, Alnylam Pharmaceuticals in RNAi therapeutics, Beam Therapeutics in CRISPR base editing, Xaira Therapeutics in AI for drug discovery, and Quantum Circuits in practical quantum computers.
01 · Says / Does
| Tag | Says | Does | Historically (to 2020) |
|---|---|---|---|
| Stages | Not stated | Not enough dated deals | Series A, Series B, Growth |
| Sectors | Biotech | Not enough dated deals | Biotech, Healthtech, Hardware, Manufacturing |
| Regions | Global | Not enough dated deals | CA, MA, WA |
Says: what the firm's funds state. Does: from 0 dated deals in the last 24 months.
Historical focus (through 2020), derived from historical deal data.
| Year | Deals | Top sectors |
|---|---|---|
| 1995 | 2 | Enterprise SaaS, Hardware |
| 1996 | 1 | Enterprise SaaS, Hardware |
| 1998 | 1 | None |
| 1999 | 4 | Consumer, Ecommerce, Edtech |
| 2000 | 17 | Biotech, Enterprise SaaS, Hardware |
| 2001 | 5 | Biotech, Hardware, Manufacturing |
| 2002 | 14 | Biotech, Hardware, Manufacturing |
| 2003 | 8 | Healthtech, Manufacturing, Advanced materials |
| 2004 | 14 | Biotech, Hardware, Healthtech |
| 2005 | 14 | Biotech, Healthtech, Advanced materials |
| 2006 | 12 | Biotech, Healthtech, Hardware |
| 2007 | 20 | Biotech, Healthtech, Hardware |
| 2008 | 11 | Biotech, Devtools, Healthtech |
| 2009 | 11 | Biotech, Healthtech, Energy |
| 2010 | 13 | Biotech, Healthtech, Manufacturing |
| 2011 | 15 | Biotech, Healthtech, Enterprise SaaS |
| 2012 | 14 | Biotech, Advanced materials, Hardware |
| 2013 | 14 | Biotech, Healthtech, Life sciences and research tools |
| 2014 | 9 | Biotech, Healthtech, Advanced materials |
| 2015 | 23 | Biotech, Healthtech, Advanced materials |
| 2016 | 23 | Biotech, Healthtech, Medical devices |
| 2017 | 22 | Biotech, Healthtech, Life sciences and research tools |
| 2018 | 26 | Biotech, Healthtech, Life sciences and research tools |
| 2019 | 25 | Biotech, Healthtech, Life sciences and research tools |
| 2020 | 16 | Biotech, Healthtech, Life sciences and research tools |
Stage mix over time
- Pre-seed
- Seed
- Series A
- Series B
- Growth
| Year | Pre-seed | Seed | Series A | Series B | Growth |
|---|---|---|---|---|---|
| 2010 | 0 | 0 | 5 | 2 | 3 |
| 2011 | 0 | 0 | 3 | 5 | 6 |
| 2012 | 0 | 0 | 1 | 0 | 7 |
| 2013 | 0 | 1 | 5 | 4 | 3 |
| 2014 | 0 | 0 | 2 | 4 | 2 |
| 2015 | 0 | 1 | 12 | 3 | 5 |
| 2016 | 0 | 0 | 15 | 4 | 3 |
| 2017 | 0 | 0 | 7 | 11 | 3 |
| 2018 | 0 | 0 | 8 | 10 | 6 |
| 2019 | 0 | 2 | 9 | 8 | 2 |
| 2020 | 0 | 1 | 9 | 4 | 2 |
| 2021 | 0 | 0 | 0 | 0 | 0 |
| 2022 | 0 | 0 | 0 | 0 | 0 |
| 2023 | 0 | 0 | 0 | 0 | 0 |
| 2024 | 0 | 0 | 0 | 0 | 0 |
| 2025 | 0 | 0 | 0 | 0 | 0 |
| 2026 | 0 | 0 | 0 | 0 | 0 |
02 · Fund history
| Fund | Year | Size | Status |
|---|---|---|---|
| ARCH Venture Fund XIV, L.P. ARCH backs disruptive science companies, following the science to found companies based on revolutionary technologies. It takes a long-term view, sizing portfolio investments as needed and partnering through formation stages toward full potential. Inferred from the firm's website | approx. 2026 | $3000M (Form D) | Raising |
| ARCH Venture Fund XIII, L.P. ARCH backs disruptive science companies, following the science to found companies based on revolutionary technologies. It takes a long-term view, sizing portfolio investments as needed and partnering through formation stages toward full potential. Inferred from the firm's website | approx. 2024 | $3000M (Form D) | Open, writing first checks |
| ARCH Venture Fund XII, L.P. ARCH backs disruptive science companies, following the science to found companies based on revolutionary technologies. It takes a long-term view, sizing portfolio investments as needed and partnering through formation stages toward full potential. Inferred from the firm's website | 2022 | $2810M to $3082.22M (Form D and SEC adviser filing) | Late investment period |
| ARCH Venture Fund XI, L.P. | 2020 | $1850M to $2396.73M (Form D and SEC adviser filing) | Follow-ons only |
03 · People across funds
- Jason Doren, General Counsel
ARCH Venture Fund XIV, L.P. (Named on Form D); ARCH Venture Fund XIII, L.P. (Named on Form D); ARCH Venture Fund XII, L.P. (Named on Form D); ARCH Venture Fund XI, L.P. (Named on Form D)
- Keith Crandell, Co-founder & Managing Director
ARCH Venture Fund XIV, L.P. (Named on Form D); ARCH Venture Fund XIII, L.P. (Named on Form D); ARCH Venture Fund XII, L.P. (Named on Form D); ARCH Venture Fund XI, L.P. (Named on Form D)
- Kristina Burow, Managing Director
ARCH Venture Fund XIV, L.P. (Named on Form D); ARCH Venture Fund XIII, L.P. (Named on Form D); ARCH Venture Fund XII, L.P. (Named on Form D); ARCH Venture Fund XI, L.P. (Named on Form D)
- Mark McDonnell, Managing Director, CFO & CAO
ARCH Venture Fund XIV, L.P. (Named on Form D); ARCH Venture Fund XIII, L.P. (Named on Form D); ARCH Venture Fund XII, L.P. (Named on Form D); ARCH Venture Fund XI, L.P. (Named on Form D)
- Paul Berns, Managing Director
ARCH Venture Fund XIV, L.P. (Named on Form D); ARCH Venture Fund XIII, L.P. (Named on Form D); ARCH Venture Fund XII, L.P. (Named on Form D); ARCH Venture Fund XI, L.P. (Team)
- Robert Nelsen, Co-founder & Managing Director
ARCH Venture Fund XIV, L.P. (Named on Form D); ARCH Venture Fund XIII, L.P. (Named on Form D); ARCH Venture Fund XII, L.P. (Named on Form D); ARCH Venture Fund XI, L.P. (Named on Form D)
- Steven Gillis, Managing Director of the GP LLC
ARCH Venture Fund XIV, L.P. (Named on Form D); ARCH Venture Fund XIII, L.P. (Named on Form D); ARCH Venture Fund XII, L.P. (Named on Form D); ARCH Venture Fund XI, L.P. (Named on Form D)
- Ari Nowacek, M.D, Ph.D., Partner
ARCH Venture Fund XIV, L.P. (Team); ARCH Venture Fund XIII, L.P. (Team); ARCH Venture Fund XII, L.P. (Team); ARCH Venture Fund XI, L.P. (Team)
- Axel Bouchon, Ph.D., Venture Partner
ARCH Venture Fund XIV, L.P. (Team); ARCH Venture Fund XIII, L.P. (Team); ARCH Venture Fund XII, L.P. (Team); ARCH Venture Fund XI, L.P. (Team)
- Brian Cuneo, Senior Partner
ARCH Venture Fund XIV, L.P. (Team); ARCH Venture Fund XIII, L.P. (Team); ARCH Venture Fund XII, L.P. (Team); ARCH Venture Fund XI, L.P. (Team)
- Carol Suh, Partner
ARCH Venture Fund XIV, L.P. (Team); ARCH Venture Fund XIII, L.P. (Team); ARCH Venture Fund XII, L.P. (Team); ARCH Venture Fund XI, L.P. (Team)
- Clinton Bybee, Co-founder & Managing Director, Emeritus
ARCH Venture Fund XIV, L.P. (Team); ARCH Venture Fund XIII, L.P. (Team); ARCH Venture Fund XII, L.P. (Team); ARCH Venture Fund XI, L.P. (Team)
- Corey Ritter, Partner
ARCH Venture Fund XIV, L.P. (Team); ARCH Venture Fund XIII, L.P. (Team); ARCH Venture Fund XII, L.P. (Team); ARCH Venture Fund XI, L.P. (Team)
- David Moore, Senior Partner
ARCH Venture Fund XIV, L.P. (Team); ARCH Venture Fund XIII, L.P. (Team); ARCH Venture Fund XII, L.P. (Team); ARCH Venture Fund XI, L.P. (Team)
- George Scangos, Ph.D., Venture Partner
ARCH Venture Fund XIV, L.P. (Team); ARCH Venture Fund XIII, L.P. (Team); ARCH Venture Fund XII, L.P. (Team); ARCH Venture Fund XI, L.P. (Team)
- Inca Coman, Ph.D., Venture Partner
ARCH Venture Fund XIV, L.P. (Team); ARCH Venture Fund XIII, L.P. (Team); ARCH Venture Fund XII, L.P. (Team); ARCH Venture Fund XI, L.P. (Team)
- Jake Bauer, Venture Partner
ARCH Venture Fund XIV, L.P. (Team); ARCH Venture Fund XIII, L.P. (Team); ARCH Venture Fund XII, L.P. (Team); ARCH Venture Fund XI, L.P. (Team)
- Jay Parrish, Ph.D., Venture Partner
ARCH Venture Fund XIV, L.P. (Team); ARCH Venture Fund XIII, L.P. (Team); ARCH Venture Fund XII, L.P. (Team); ARCH Venture Fund XI, L.P. (Team)
- John Maraganore, Ph.D., Venture Partner
ARCH Venture Fund XIV, L.P. (Team); ARCH Venture Fund XIII, L.P. (Team); ARCH Venture Fund XII, L.P. (Team); ARCH Venture Fund XI, L.P. (Team)
- Jordan Zwick, Venture Partner
ARCH Venture Fund XIV, L.P. (Team); ARCH Venture Fund XIII, L.P. (Team); ARCH Venture Fund XII, L.P. (Team); ARCH Venture Fund XI, L.P. (Team)
- Joseph Jeong, Ph.D., Venture Partner
ARCH Venture Fund XIV, L.P. (Team); ARCH Venture Fund XIII, L.P. (Team); ARCH Venture Fund XII, L.P. (Team); ARCH Venture Fund XI, L.P. (Team)
- Kevin Hrusovsky, Venture Partner
ARCH Venture Fund XIV, L.P. (Team); ARCH Venture Fund XIII, L.P. (Team); ARCH Venture Fund XII, L.P. (Team); ARCH Venture Fund XI, L.P. (Team)
- Luciana Borio, M.D., Venture Partner
ARCH Venture Fund XIV, L.P. (Team); ARCH Venture Fund XIII, L.P. (Team); ARCH Venture Fund XII, L.P. (Team); ARCH Venture Fund XI, L.P. (Team)
- Mary Chamberlain-Tharp, Ph.D., Venture Partner
ARCH Venture Fund XIV, L.P. (Team); ARCH Venture Fund XIII, L.P. (Team); ARCH Venture Fund XII, L.P. (Team); ARCH Venture Fund XI, L.P. (Team)
- Mayu Yoshikawa, Ph.D., Venture Partner
ARCH Venture Fund XIV, L.P. (Team); ARCH Venture Fund XIII, L.P. (Team); ARCH Venture Fund XII, L.P. (Team); ARCH Venture Fund XI, L.P. (Team)
- Nilay Thakar, Ph.D., Principal
ARCH Venture Fund XIV, L.P. (Team); ARCH Venture Fund XIII, L.P. (Team); ARCH Venture Fund XII, L.P. (Team); ARCH Venture Fund XI, L.P. (Team)
- Olivia Zetter, Strategic Advisor & Venture Partner
ARCH Venture Fund XIV, L.P. (Team); ARCH Venture Fund XIII, L.P. (Team); ARCH Venture Fund XII, L.P. (Team); ARCH Venture Fund XI, L.P. (Team)
- Patrick Weiss, Venture Partner
ARCH Venture Fund XIV, L.P. (Team); ARCH Venture Fund XIII, L.P. (Team); ARCH Venture Fund XII, L.P. (Team); ARCH Venture Fund XI, L.P. (Team)
- Peter Mintun, Ph.D, Associate
ARCH Venture Fund XIV, L.P. (Team); ARCH Venture Fund XIII, L.P. (Team); ARCH Venture Fund XII, L.P. (Team); ARCH Venture Fund XI, L.P. (Team)
- Richard Heyman, Ph.D., Venture Partner
ARCH Venture Fund XIV, L.P. (Team); ARCH Venture Fund XIII, L.P. (Team); ARCH Venture Fund XII, L.P. (Team); ARCH Venture Fund XI, L.P. (Team)
- Sean Kendall, Partner (Europe)
ARCH Venture Fund XIV, L.P. (Team); ARCH Venture Fund XIII, L.P. (Team); ARCH Venture Fund XII, L.P. (Team); ARCH Venture Fund XI, L.P. (Team)
- Steve Gillis, Ph.D., Managing Director
ARCH Venture Fund XIV, L.P. (Team); ARCH Venture Fund XIII, L.P. (Team); ARCH Venture Fund XII, L.P. (Team); ARCH Venture Fund XI, L.P. (Team)
- Vicki Sato, Ph.D., Venture Partner
ARCH Venture Fund XIV, L.P. (Team); ARCH Venture Fund XIII, L.P. (Team); ARCH Venture Fund XII, L.P. (Team); ARCH Venture Fund XI, L.P. (Team)
04 · Recent deals
No dated deals found yet.
05 · Latest from the firm
No news from the firm's website yet.
06 · Sources
- HTTP://ARCHVENTURE.COM
- https://www.archventure.com/team/
- https://www.archventure.com/portfolio/
- https://www.archventure.com/about/
Fund dates and sizes are from SEC Form D filings.
Last verified: Oct 28, 2026